Navigation Links
Staying Active May Help Prevent Dementia
Date:7/14/2014

MONDAY, July 14, 2014 (HealthDay News) -- Being physically active in middle age appears to help reduce your risk for Alzheimer's disease and other types of dementia, suggest the findings from two new studies.

"In our studies, we found that physical exercise at various levels, especially in midlife, is beneficial for cognitive function," Dr. Yonas Geda from the Mayo Clinic, said in an Alzheimer's Association news release.

"These are intriguing results, but they are not yet conclusive. More research is needed to determine the extent and nature of physical activity in protecting against MCI [mild cognitive impairment] and dementia," Geda added.

One study included 280 seniors who were asked about their physical activity levels over their lifetime. The median age of the study volunteers was 81, which means half were under that age and half were older than 81. All of the study participants had early signs of memory and thinking problems (mild cognitive impairment). People with mild cognitive impairment have a higher risk for Alzheimer's disease.

After about three years, the researchers found that people with a history of moderate physical activity in middle age had a significantly decreased risk of developing dementia.

Light or vigorous exercise in middle age, or any level of physical activity later in life was not associated with a decreased risk of mild cognitive impairment progressing to dementia.

The second study included 1,830 older adults with normal memory and thinking abilities who were asked about their physical activity levels in midlife and late life and then followed for an average of just over three years.

Light physical activity in midlife and late life was associated with a decreased risk of developing mild cognitive impairment, as were vigorous midlife and moderate late-life physical activity.

Neither study was designed to prove that exercise could directly cause a decline in the rates of dementia or Alzheimer's; they were designed to find a link between these factors.

Both studies were conducted by Mayo Clinic researchers and presented Monday at the Alzheimer's Association International Conference in Copenhagen, Denmark. Findings presented at meetings are generally viewed as preliminary until published in a peer-reviewed journal.

"Determining more specifically the factors that raise and lower risk of Alzheimer's disease and other dementias is an essential component in our battle against the Alzheimer's epidemic," Heather Snyder, the Alzheimer's Association director of Medical and Scientific Operations, said in the news release.

"We are now getting a more clear idea of the opportunities for risk reduction through behavior changes and other health factors. We're learning that Alzheimer's risk and protective factors may change over the course of our lives," she said of the studies.

More information

The U.S. National Institute on Aging has more about Alzheimer's disease risk factors and prevention.

SOURCE: Alzheimer's Association, news release, July 14, 2014

--


'/>"/>
Copyright©2014 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Naral Pro-Choice Colorado & Planned Parenthood Of The Rocky Mountains Statement On Udall & Degette Staying In Dc To Introduce Legislation
2. In Light of Increased Levels of Personal Stress Over the Holiday Season, Lanahan Insurance Recommends Staying Covered with Health Insurance
3. Staying on medication may not translate to avoiding readmission
4. Middleman Productions Announces that Provocative "Staying Grounded" Exhibit Finds Its Wings in Locations Around Massachusetts
5. New Blog Post from iHealthology.com Announces Why Staying Fit Means Getting on the Move
6. Staying Home With Sick Kids Causes Job Worries for Parents: Survey
7. Active shooter training increases comfort level of emergency responders
8. New drug active against most aggressive type of lung cancer cells
9. Most prostate cancer specialists dont recommend active surveillance for low-risk patients
10. Keeping active pays off even in your 70s and 80s
11. A new Kabuto-like nickel catalyst forms bioactive frameworks from phenol derivatives
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Staying Active May Help Prevent Dementia
(Date:3/30/2017)... Washington, DC (PRWEB) , ... March 30, 2017 ... ... scientists and organizations submitted a letter to President Trump expressing their support for ... two medical doctors, two Ph.D. scientists and one medical journalist, will hold a ...
(Date:3/29/2017)... York City, NY (PRWEB) , ... March 29, ... ... body for men’s and women’s professional squash, announced it has enlisted New York ... partner. The agency will develop and procure sponsorship opportunities for the Professional ...
(Date:3/29/2017)... Amherst, Massachusetts (PRWEB) , ... March 30, 2017 , ... ... has had great success and feedback from high school and college students who have ... is being held July 7-23 and YFI is now accepting applications for enrollment. ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... a Walgreens store in Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and BeautyBest, ... southeastern states. Ingredients in HeartBoost, an over the counter heart healthy drink, can ...
(Date:3/29/2017)... ... March 29, 2017 , ... Dr. Angela Cotey, a noted general ... accepting new pediatric patients, with or without a referral. Dr. Cotey knows that ... orthodontic outcome and experience. When patients receive early treatment, they may achieve straight teeth ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Mar. 29, 2017 Research and Markets ... Market 2014 - 2025" report to their offering. ... The ... 303.7 million by 2025. Increasing geriatric population prone to orthopedic ... orthopedic navigation systems over the forecast period. Osteoarthritis and osteoporosis ...
(Date:3/29/2017)... , March 29, 2017  Experts in ... remote monitoring devices like  Soberlink Systems  as a ... consensus paper, published in early 2017, concluded that ... valuable in managing patient recovery." The ... Journal of Addiction Medicine, detail a range of ...
(Date:3/29/2017)...  Glenmark Pharmaceuticals, a global pharmaceutical company, today ... fixed-dose combination of mometasone furoate (25 mcg) and ... nasal spray being studied for the treatment of ... recently completed Phase 3 trial assessing the efficacy ... mometasone, olopatadine or placebo. "We continue ...
Breaking Medicine Technology: